Court approves $7.25 billion Bayer settlement over Roundup cancer claims
A Missouri judge approved a settlement Friday requiring Bayer to pay up to $7.25 billion to resolve cancer claims linked to its Roundup weedkiller, according to WCBD Count on 2 and WTOP. The settlement covers thousands of people across the country who say they developed non-Hodgkin lymphoma, a type of cancer, from using the product.
Participants in the settlement could receive an average of between $10,000 and $165,000 each, depending on how they used Roundup, their age when diagnosed and how severe their illness is, according to WTOP. The payments will be distributed over two decades. The settlement covers both people already diagnosed with cancer and those who may develop it in the future.
Bayer, a Germany-based company, has denied that Roundup causes cancer but agreed to the settlement to avoid mounting legal costs and potential bankruptcy, according to WTOP. The company has already changed the formula for Roundup sold to homeowners. Some lawyers for cancer patients argued the payouts are too small, but others said the deal was better than risking nothing after a U.S. Supreme Court ruling in June that limited their ability to sue in state courts.
According to WTOP, the judge said the average payouts are "fair and adequate" and the total settlement is "among the largest in the history of mass tort personal-injury class action settlements." The settlement includes $600 million for attorneys' fees.
Sources
- WCBD Count on 2: Court approves $7.25 billion settlement with Bayer over claims Roundup weedkiller caused cancer
- WTOP: Court approves $7.25 billion settlement with Bayer over claims Roundup weedkiller caused cancer
